BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2831735)

  • 1. Function and structure of parietal cells after H+-K+-ATPase blockade.
    Fryklund J; Helander HF; Elander B; Wallmark B
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G399-407. PubMed ID: 2831735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
    Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific labelling of gastric H+,K+-ATPase by omeprazole.
    Fryklund J; Gedda K; Wallmark B
    Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat parietal cell function after prolonged inhibition of gastric acid secretion.
    Larsson H; Carlsson E; Ryberg B; Fryklund J; Wallmark B
    Am J Physiol; 1988 Jan; 254(1 Pt 1):G33-9. PubMed ID: 2827515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
    Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
    Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
    Fryklund J; Wallmark B
    J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells.
    Karam SM; Forte JG
    Am J Physiol; 1994 Apr; 266(4 Pt 1):G745-58. PubMed ID: 8179010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of HOE 731 in isolated rabbit gastric glands.
    Herling AW; Becht M; Lang HJ; Scheunemann KH; Weidmann K; Scholl T; Rippel R
    Biochem Pharmacol; 1990 Oct; 40(8):1809-14. PubMed ID: 2173590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
    Batzri S; Brugada O; Harmon JW; Rich NM
    J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
    Nagaya H; Inatomi N; Nohara A; Satoh H
    Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
    Wallmark B; Larsson H; Humble L
    J Biol Chem; 1985 Nov; 260(25):13681-4. PubMed ID: 2997178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
    Yamamoto O; Tanaka H; Ueda F; Kimura K
    Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of gastric acid secretion in the fetal rabbit.
    Yee LF; Andrews KJ; Calaustro EQ; Grady EF; Mulvihill SJ
    Surgery; 1995 Aug; 118(2):199-205. PubMed ID: 7638734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.